×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd., | 2.95 | -1.93 | NA | -7.86 | 0 | |
| SUVEN LIFE SCIENCES LTD. | 46.97 | -773.10 | 9.19 | -3.48 | 5,147 | |
| SEQUENT SCIENTIFIC LTD. | 4261.4 | 196.0 | 4239.9 | 0.58 | 4770 | 158.0 |
| Dishman Carbogen Amcis Limited | 714.7 | -136.0 | 603.0 | -0.87 | 4410 | 37.1 |
Suven Life Sciences Ltd., with Security Code 530239, is a leading player in the Healthcare Research- Analytics & Technology industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 2.5 | 2.4 | 1.0 | 2.6 | 1.6 | 1.5 | 1.9 | 0.9 |
| Expenses | 11.6 | 9.3 | 11.1 | 16.2 | 14.9 | 16.4 | 15.9 | 18.8 |
| Operating Profit | -9.2 | -6.9 | -10.1 | -13.6 | -13.3 | -14.9 | -14.0 | -17.9 |
| OPM % | -375.28% | -288.05% | -1002.78% | -529.97% | -826.02% | -1014.72% | -749.81% | -1948.42% |
| Other Income | 6.1 | 4.3 | 3.9 | 4.0 | 1.6 | 1.2 | 0.6 | 3.8 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 1.6 | 1.5 | 1.5 | 1.5 | 1.5 | 1.3 | 1.4 | 1.3 |
| Profit before tax | -4.8 | -4.1 | -7.7 | -11.1 | -13.3 | -15.0 | -14.8 | -15.4 |
| Tax % | 0% | -24.3% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -4.8 | -3.1 | -7.7 | -11.1 | -13.3 | -15.1 | -14.8 | -15.4 |
| EPS in Rs | -0.22 | -0.14 | -0.35 | -0.51 | -0.61 | 0 | -0.68 | -0.7 |
| Metrics | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 3.1 | 2.5 | 2.4 | 1.0 | 2.6 | 1.6 | 1.5 | 0.9 |
| Expenses | 26.6 | 48.6 | 32.7 | 31.5 | 54.8 | 40.8 | 45.3 | 80.7 |
| Operating Profit | -23.5 | -46.2 | -30.3 | -30.5 | -52.2 | -39.2 | -43.8 | -79.8 |
| OPM % | -768.3% | -1884.62% | -1269.94% | -3035.69% | -2029.07% | -2435.09% | -2984.73% | -8680.2% |
| Other Income | 12.6 | 6.1 | 4.3 | 4.0 | 4.0 | 1.6 | 1.2 | 3.8 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 1.7 | 1.6 | 1.5 | 1.5 | 1.5 | 1.5 | 1.3 | 1.3 |
| Profit before tax | -20.1 | -41.8 | -27.5 | -28.0 | -49.6 | -39.1 | -43.9 | -77.3 |
| Tax % | 0% | 0% | -3.6% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -12.7 | -41.8 | -26.5 | -28.0 | -49.6 | -39.1 | -43.9 | -77.3 |
| EPS in Rs | -0.58 | -1.92 | -1.22 | -1.29 | -2.27 | -1.79 | 0 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -35% |
| 5 Years: | -12% |
| 3 Years: | -17% |
| TTM: | -43% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | -6% |
| TTM: | -135% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 46% |
| 3 Years: | 44% |
| 1 Year: | 119% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -35% |
| 5 Years: | -12% |
| 3 Years: | -17% |
| TTM: | -43% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -21% |
| 3 Years: | -10% |
| TTM: | -37% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 46% |
| 3 Years: | 44% |
| 1 Year: | 119% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|